Brain parenchymal angiomatoid fibrous histiocytoma and spinal myxoid mesenchymal tumor with FET: CREB fusion, a spectrum of the same tumor type
Neuropathology · 2022-08 · 42 (4) · 257-268
DOI: 10.1111/neup.12814 ↗Kurz gefasst
Fallbericht in der Zeitschrift Neuropathology, online erschienen am 22.06.2022. Verfasst von Na Rae Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Gachon University Gil Medical Center, Incheon, South Korea. Hauptthemen laut MEDLINE: Histiocytoma, Benign Fibrous, Spinal Cord Neoplasms, Spinal Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Institute for Information and Communications Technology Promotion, National Cancer Center, Republic of Korea.
Abstract (Originalsprache)
Angiomatoid fibrous histiocytomas (AFH) is a rare soft tissue tumor of intermediate malignant potential, and its histology is diverse. It can occur in several organs including intracranial and soft tissues. Here, we report two cases of brain parenchymal classic AFH and spinal extramedullary myxoid mesenchymal tumor with clinicopathological and molecular investigations by next‐generation sequencing and a comprehensive review. The current brain parenchymal AFH occurred in a 79‐year‐old woman, and the spinal myxoid mesenchymal tumor arose in the thoracic spine of a 28‐year‐old woman; both harbored FET:CREB fusion. The current brain parenchymal AFH has not recurred for 15‐months follow‐up period, but the spinal myxoid mesenchymal tumor recurred three times and metastasized to T8 spine level for 30‐months follow‐up period. We reviewed 40 reported cases of central nervous system (CNS) AFHs/myxoid mesenchymal tumors including our two cases to identify clinicopathological features and biological behaviors. They occur with a slight female predominance (M:F = 1:1.7) in children and young adults (median age: 17 years; range: 4–79 years old). Approximately 80% of CNS AFHs were younger than 30 year. Most of them were dura‐based and were not just intracranial tumors as they occurred anywhere in the CNS including spinal dura. EWSR1 rearrangement was the most common driver (98%), including FET:CREB (33%), EWSR1:ATF1 (30%), and EWSR1:CREM (27%) fusions, but FUS:CREM fusion (2%) was also present. During the follow‐up period (median: 27 months), 43% (17/40) of CNS AFHs recurred between two months and 11 years, and multiple recurrences were also observed. One case showed metastases to the lymph nodes and vertebrae, and among 11 cases that resulted in death, four cases provided available clinical data. Because these tumors are identical to soft tissue AFH or primary pulmonary myxoid sarcoma with an FET:CREB fusion in morphological and immunohistochemical spectra, the authors propose incorporating the two tumor terms into one.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Gachon University Gil Medical Center, Incheon, South Korea.
- Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Department of Neurosurgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Department of Genomic Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Institute of Neuroscience, Seoul National University College of Medicine, Seoul, Korea.
ORCID-Profile: Na Rae Kim, Seong-Ik Kim, Jin Woo Park, Chul-Kee Park, Chun Kee Chung, Seung-Hong Choi, Hongseok Yun, Sung-Hye Park
Förderung
- Institute for Information and Communications Technology Promotion
- National Cancer Center, Republic of Korea
Zitieren
APA
Kim, N. R., Kim, S. I., Park, J. W., Park, C. K., Chung, C. K., Choi, S. H., Yun, H., & Park, S. H. (2022). Brain parenchymal angiomatoid fibrous histiocytoma and spinal myxoid mesenchymal tumor with FET: CREB fusion, a spectrum of the same tumor type. Neuropathology, 42(4), 257-268. https://doi.org/10.1111/neup.12814
Vancouver
Kim NR, Kim SI, Park JW, Park CK, Chung CK, Choi SH, et al. Brain parenchymal angiomatoid fibrous histiocytoma and spinal myxoid mesenchymal tumor with FET: CREB fusion, a spectrum of the same tumor type. Neuropathology. 2022;42(4):257-268. doi:10.1111/neup.12814
BibTeX
@article{Kim2022,
author = {Kim, Na Rae and Kim, Seong-Ik and Park, Jin Woo and Park, Chul-Kee and Chung, Chun Kee and Choi, Seung-Hong and Yun, Hongseok and Park, Sung-Hye},
title = {Brain parenchymal angiomatoid fibrous histiocytoma and spinal myxoid mesenchymal tumor with FET: CREB fusion, a spectrum of the same tumor type},
journal = {Neuropathology},
year = {2022},
volume = {42},
number = {4},
pages = {257--268},
doi = {10.1111/neup.12814}
}
EUVIMED